Related Experiment Video
Updated: Jul 16, 2026

Through-the-Wall Blood Sampling Method to Minimize Sleep Disruption in Clinical Settings
Published on: June 13, 2025
Low molecular weight heparin prophylaxis in day case surgery
J Shabbir1, P F Ridgway, W Shields
1Dept of Surgery, Wexford General Hospital, Wexford. Jshabbir@aol.com
The use of low molecular weight heparins (LMWH) in day case surgery varies widely, with many surgeons lacking confidence in protocol adherence. This highlights a need for standardized LMWH prophylaxis guidelines in short-stay procedures.
Area of Science:
- Surgical prophylaxis
- Pharmacology
- Venous thromboembolism prevention
Background:
- The efficacy and safety of low molecular weight heparins (LMWH) in day case and short-stay surgical settings remain largely uncharacterized.
- Current clinical practice regarding LMWH prophylaxis in these procedures is not well understood.
Purpose of the Study:
- To investigate and describe the current national utilization patterns of LMWH prophylaxis.
- Focus on specific day and short-stay surgical procedures.
Main Methods:
- A national survey was conducted using a standardized, anonymous postal questionnaire.
- Distributed to all consultant general surgeons in Ireland.
- Targeted operations included herniorraphy, anorectal procedures, varicose vein surgery, and laparoscopic cholecystectomy.
Main Results:
- A response rate of 68.3% was achieved from 82 surveyed surgeons.
- 54% reported having a protocol for LMWH administration in day case surgery, but 41% lacked confidence in protocol adherence.
- 59% stratified patients by individual risk; 13% reported post-day case venous thromboembolism (VTE).
Conclusions:
- The study reveals significant heterogeneity in LMWH administration practices for day case surgery.
- The absence of validated, published protocols necessitates the development of consensus guidelines.
- A standardized day case protocol for LMWH prophylaxis is proposed.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Peripheral Artery Disease V: Postoperative Nursing Management
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care